Miller Christopher B, Valenti Lisa, Harrison Christopher M, Bartlett Delwyn J, Glozier Nick, Cross Nathan E, Grunstein Ronald R, Britt Helena C, Marshall Nathaniel S
CIRUS, Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, The University of Sydney, New South Wales, Australia.
Family Medicine Research Centre, School of Public Health, Sydney Medical School, The University of Sydney, New South Wales, Australia.
J Clin Sleep Med. 2017 Jun 15;13(6):785-790. doi: 10.5664/jcsm.6616.
To evaluate changes in rates of family physician (FP) management of insomnia in Australia from 2000-2015.
The Bettering the Evaluation And Care of Health (BEACH) program is a nationally representative cross-sectional survey of 1,000 newly randomly sampled family physicians' activity in Australia per year, who each record details of 100 consecutive patient encounters. This provided records of approximately 100,000 encounters each year. We identified all encounters with patients older than 15 years where insomnia or difficulty sleeping was managed and assessed trends in these encounters from 2000-2015.
There was no change in the management rate of insomnia from 2000-2007 (1.54 per 100 encounters [95% confidence interval [CI]: 1.49-1.58]). This rate was lower from 2008-2015 (1.31 per 100 encounters [95% CI: 1.27-1.35]). There was no change in FP management: pharmacotherapy was used in approximately 90% of encounters; nonpharmacological advice was given at approximately 20%; and onward referral at approximately 1% of encounters. Prescription of temazepam changed from 54.6 [95% CI: 51.4-57.9] per 100 insomnia problems in 2000-2001 to 43.6 [95% CI: 40.1-47.0] in 2014-2015, whereas zolpidem increased steadily from introduction in 2000 to 14.6 [95% CI: 12.2-17.1] per 100 insomnia problems in 2006-2007, and then decreased to 7.3 [95% CI: 5.4-9.2] by 2014-2015.
Insomnia management frequency decreased after 2007 in conjunction with ecologically associated Australian media reporting of adverse effects linked to zolpidem use. Australian FPs remain reliant on pharmacotherapy for the management of insomnia.
评估2000年至2015年澳大利亚家庭医生对失眠症的管理率变化。
改善健康评估与护理(BEACH)项目是一项具有全国代表性的横断面调查,每年对1000名新随机抽取的澳大利亚家庭医生的活动进行调查,每位医生记录连续100次患者诊疗的详细信息。这样每年可提供约10万次诊疗记录。我们确定了所有对15岁以上失眠或睡眠困难患者的诊疗,并评估了2000年至2015年这些诊疗的趋势。
2000年至2007年失眠症的管理率没有变化(每100次诊疗1.54例[95%置信区间(CI):1.49 - 1.58])。2008年至2015年该率较低(每100次诊疗1.31例[95% CI:1.27 - 1.35])。家庭医生的管理方式没有变化:约90%的诊疗使用药物治疗;约20%的诊疗提供非药物建议;约1%的诊疗进行转诊。替马西泮的处方量从2000 - 2001年每100例失眠问题54.6例[95% CI:51.4 - 57.9]降至2014 - 2015年的43.6例[95% CI:40.1 - 47.0],而唑吡坦从2000年引入后稳步增加,在2006 - 2007年达到每100例失眠问题14.6例[95% CI:12.2 - 17.1],然后到2014 - 2015年降至7.3例[95% CI:5.4 - 9.2]。
2007年后失眠症管理频率下降,与此同时澳大利亚媒体有与使用唑吡坦相关的不良反应的生态关联报道。澳大利亚家庭医生在失眠症管理上仍依赖药物治疗。